The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
Abstract
Co-encapsulated doxorubicin (DOX) and curcumin (CUR) in poly(butyl cyanoacrylate) nanoparticles (PBCA-NPs) were prepared with emulsion polymerization and interfacial polymerization. The mean particle size and mean zeta potential of CUR-DOX-PBCA-NPs were 133 ± 5.34 nm in diameter and +32.23 ± 4.56 mV, respectively. The entrapment efficiencies of doxorubicin and curcumin were 49.98 ± 3.32% and 94.52 ± 3.14%, respectively. Anticancer activities and reversal efficacy of the formulations and various combination approaches were assessed using 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazolium bromide assay and western blotting. The results showed that the dual-agent loaded PBCA-NPs system had the similar cytotoxicity to co-administration of two single-agent loaded PBCA-NPs (DOX-PBCA-NPs+CUR-PBCA-NPs), which was slightly higher than that of the free drug combination (DOX+CUR) and one free drug/another agent loaded PBCA-NPs combination (DOX+CUR-PBCA-NPs or CUR+DOX-PBCA-NPs). The simultaneous administration of doxorubicin and curcumin achieved the highest reversal efficacy and down-regulation of P-glycoprotein in MCF-7/ADR cell lines, an MCF-7 breast carcer cell line resistant to adriamycin. Multidrug resistance can be enhanced by combination delivery of encapsulated cytotoxic drugs and reversal agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Especially, anticancer drugs encapsulated in polymeric micelles have shown a better accumulation in the targeted site, thus reducing side effects on noncancerous tissues [46,47,48].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [46]
Citations
Cites
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 2,550
Aggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,139
Cheng, A., Hsu, C., Lin, J., Hsu, M. M., Ho, Y., Shen, T. S., Ko, J. Y., Lin, J.-T., Lin, B., Ming-Shiang, W., et al. (2001) · PubMed · Cited by 2,071
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,083
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
Vauthier, C., Dubernet, C., Fattal, E., Pinto‐Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 537
Targeted nanoparticles for cancer therapy
Gu, F., Karnik, R., Wang, A. Z., Alexis, F., Levy‐Nissenbaum, E., Hong, S., Langer, R., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 520
Ganta, S., & Amiji, M. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800240j · Cited by 489
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Notarbartolo, M., Poma, P., Perri, D., Dusonchet, L., Cervello, M., & D’Alessandro, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.051 · Cited by 317
Cited by
Sorted by citations
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 856
Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds
Esfanjani, A. F., & Jafari, S. M. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.06.053 · Cited by 556
Recent progress in nanomedicine for enhanced cancer chemotherapy
Wei, G., Wang, Y., Yang, G. Y., Wang, Y., & Ju, R. (2021) · Theranostics · doi:10.7150/thno.57828 · Cited by 484
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A. K., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 400
Niosomes: A review on niosomal research in the last decade
Bhardwaj, P., Tripathi, P., Gupta, R., & Pandey, S. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101581 · Cited by 367
Recent advances of controlled drug delivery using microfluidic platforms
Sanjay, S. T., Zhou, W., Dou, M., Tavakoli, H., Ma, L., Xu, F., & Li, X. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.013 · Cited by 365
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Avramović, N., Mandić, B., Savic-Radojevic, A. R., & Simic, T. P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040298 · Cited by 312
The Promise of Nanotechnology in Personalized Medicine
Alghamdi, M. A., Fallica, A. N., Virzì, N. F., Kesharwani, P., Pittalà, V., & Greish, K. F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050673 · Cited by 324
Different strategies to overcome multidrug resistance in cancer
Manju, S., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 259
Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer
Tan, B. L., & Norhaizan, M. E. (2019) · Molecules · doi:10.3390/molecules24142527 · Cited by 246
Controlled Drug Release from Nanoengineered Polysaccharides
Bayer, I. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051364 · Cited by 245
Recent advances in curcumin nanoformulation for cancer therapy
Lee, W., Loo, C., Young, P. M., Traini, D., Mason, R. S., & Rohanizadeh, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.916686 · Cited by 232
Rationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205
Zhang, J., Li, J., Shi, Z., Yang, Y., Xie, X., Lee, S. M., Wang, Y., Leong, K. W., & Chen, M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.04.029 · Cited by 195
Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review
Mohajeri, M., & Sahebkar, A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.005 · Cited by 196
Alemi, A., Reza, J. Z., Haghiralsadat, F., Jaliani, H. Z., Karamallah, M. H., Hosseini, S. A., & Karamallah, S. H. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0351-4 · Cited by 194
Curcumin Nanomedicine: A Road to Cancer Therapeutics
Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289219 · Cited by 193
Kim, J., Yung, B. C., Kim, W. J., & Chen, X. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.026 · Cited by 191
Nanoformulations for combination or cascade anticancer therapy
Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.003 · Cited by 178
Zhang, J., Hu, K., Di, L., Wang, P., Liu, Z., Zhang, J., Yue, P., Song, W., Zhang, J., Chen, T., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113964 · Cited by 189
Self-citationCastillo, R. R., Colilla, M., & Vallet‐Regí, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1211637 · Cited by 181
Zhao, X., Chen, Q., Li, Y.-S., Tang, H., Liu, W., & Yang, X. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.003 · Cited by 167
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Khatoon, E., Banik, K., Harsha, C., Sailo, B. L., Thakur, K. K., Khwairakpam, A. D., Vikkurthi, R., Devi, T. B., Gupta, S. C., & Kunnumakkara, A. B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.014 · Cited by 163
Ngwabebhoh, F. A., Erdağı, S. İ., & Yıldız, U. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.079 · Cited by 162
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156
Mohanta, V., Madras, G., & Patil, S. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am505681e · Cited by 155
Barui, S., Saha, S., Mondal, G., Haseena, S., & Chaudhuri, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.074 · Cited by 134
Naderinezhad, S., Amoabediny, G., & Haghiralsadat, F. (2017) · RSC Advances · doi:10.1039/c7ra01736g · Cited by 131
Tahir, N., Madni, A., Correia, A., Rehman, M., Balasubramanian, V., Khan, M. M., & Santos, H. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s209325 · Cited by 129
Liu, W., Zhao, X., Chen, Q., Li, Y.-S., Tang, H., Liu, X., & Yang, X. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73322 · Cited by 126
Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Eslami, M., Memarsadeghi, O., Davarpanah, A., Arti, A., Nayernia, K., & Behnam, B. (2024) · Biomedicines · doi:10.3390/biomedicines12010183 · Cited by 134
Gomez‐Zepeda, D., Taghi, M., Scherrmann, J., Declèves, X., & Menet, M. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010020 · Cited by 131
Feng, Q., Sun, J.-S., & Jiang, X.-Y. (2016) · Nanoscale · doi:10.1039/c5nr07964k · Cited by 99
Fang, J., Lai, Y., Chiu, T., Chen, Y., Hu, S., & Chen, S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300598 · Cited by 120
Self-citationSadeghi, R., Moosavi‐Movahedi, A. A., Emam‐Djomeh, Z., Kalbasi, A., Razavi, S. H., Karimi, M., & Kokini, J. L. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2565-1 · Cited by 115
Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives
Lopes-Rodrigues, V., Sousa, E., & Vasconcelos, M. H. (2016) · Pharmaceuticals · doi:10.3390/ph9040071 · Cited by 116
Nano-sized polymers and liposomes designed to deliver combination therapy for cancer
Eldar‐Boock, A., Polyak, D., Scomparin, A., & Satchi‐Fainaro, R. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.04.014 · Cited by 112
Zhang, Y., Hou, Z., Ge, Y., Deng, K., Liu, B., Li, X., Li, Q., Cheng, Z., Ma, P., Li, C., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b05522 · Cited by 110
Self-citationGharieh, A., Khoee, S., & Mahdavian, A. R. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.04.010 · Cited by 110
Ashrafizadeh, M., Hushmandi, K., Mirzaei, S., Bokaie, S., Bigham, A., Makvandi, P., Rabiee, N., Thakur, V. K., Kumar, A. P., Sharifi, E., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10325 · Cited by 114
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Yadav, P., Ambudkar, S. V., & Prasad, N. R. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01626-z · Cited by 109
Pan, J., Rostamizadeh, K., Filipczak, N., & Torchilin, V. P. (2019) · Molecules · doi:10.3390/molecules24061035 · Cited by 104
Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications
Udompornmongkol, P., & Chiang, B.-H. (2015) · Journal of Biomaterials Applications · doi:10.1177/0885328215594479 · Cited by 101
Kong, F., Wang, W., Xi, M., Duan, X., & Wang, Y. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80297 · Cited by 100
Danafar, H., Davaran, S., Rostamizadeh, K., Valizadeh, H., & Hamidi, M. (2014) · Europe PMC (PubMed Central) · doi:10.5681/apb.2014.074 · Cited by 100
Polymer assembly: Promising carriers as co-delivery systems for cancer therapy
Li, N., Zhao, L., Qi, L., Li, Z., & Luan, Y. (2015) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.10.009 · Cited by 96
Ma, W., Guo, Q., Li, Y., Wang, X., Wang, J., & Tu, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.033 · Cited by 96
Self-citationCurcumin as tyrosine kinase inhibitor in cancer treatment
Golonko, A., Lewandowska, H., Świsłocka, R., Jasińska, U., Priebe, W., & Lewandowski, W. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.015 · Cited by 96
Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs
Tesauro, D., Accardo, A., Aloj, L., Morelli, G., & Aurilio, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s53593 · Cited by 93
Cancer-linked targets modulated by curcumin.
Hasima, N., & Aggarwal, B. B. (2012) · PubMed Central · Cited by 92
Cockle Shell-Derived Calcium Carbonate (Aragonite) Nanoparticles: A Dynamite to Nanomedicine
Mailafiya, M. M., Abubakar, K., Danmaigoro, A., Chiroma, S. M., Rahim, E. B. A., Moklas, M. A. M., & Zakaria, Z. A. B. (2019) · Applied Sciences · doi:10.3390/app9142897 · Cited by 89
Cui, T., Zhang, S., & Sun, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5345 · Cited by 88
Ahmad, M. Z., Alkahtani, S. A., Akhter, S., Ahmad, F. J., Ahmad, J., Akhtar, M. S., Mohsin, N., & Abdel‐Wahab, B. A. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1055570 · Cited by 87
Heidari, A. (2017) · Archives of Biotechnology and Biomedicine · doi:10.29328/journal.hjb.1001007 · Cited by 85
Ma, W., Wang, J., Guo, Q., & Tu, P. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.04.007 · Cited by 80
Self-citationWang, Y., Dou, L., He, H., Zhang, Y., & Shen, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400547u · Cited by 78
Self-citationThe potential of multi-compound nanoparticles to bypass drug resistance in cancer
Silva, C. G. D., Peters, G. J., OSSENDORP, F. A., & Cruz, L. J. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3427-1 · Cited by 80
Heidari, A. (2018) · International Journal of Advanced Chemistry · doi:10.14419/ijac.v6i2.12528 · Cited by 78
Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience
Shabani, L., Abbasi, M., Azarnew, Z., Amani, A. M., & Vaez, A. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-022-01062-y · Cited by 82
Gagliardi, A., Bonacci, S., Paolino, D., Celia, C., Procopio, A., Fresta, M., & Cosco, D. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02422 · Cited by 78
Wang, J., Ma, W., & Tu, P. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500043 · Cited by 77
Self-citationSesărman, A., Tefas, L. R., Sylvester, B., Licărete, E., Rauca, V. F., Lupuţ, L., Pătraș, L., Porav, A. S., Banciu, M., & Porfire, A. S. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-00598-8 · Cited by 77
Chitosan: A versatile bio-platform for breast cancer theranostics
Madamsetty, V. S., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Schneible, J. D., Fatemi, I., Shirvani, A., Zarrabi, A., Azedi, F., Dehshahri, A., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.012 · Cited by 74
Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy
Liew, H. S., Mai, C., Zulkefeli, M., Madheswaran, T., Kiew, L. V., Delsuc, N., & Low, M. L. (2020) · Molecules · doi:10.3390/molecules25184176 · Cited by 75
Heidari, A. (2018) · Journal of Advances in Nanomaterials · doi:10.22606/jan.2018.31001 · Cited by 74
Delivery of natural phenolic compounds for the potential treatment of lung cancer
Muller, A. G., Sarker, S. D., Saleem, I. Y., & Hutcheon, G. A. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00267-2 · Cited by 76
Song, Y. H., De, R., & Lee, K. T. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.103008 · Cited by 78
Prados, J. C., Cabeza, L., Ortíz, R., Arias, J. L., Adolfina, M. A., Entrena, J. M., Luque, R., & Melguizo, C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74378 · Cited by 71
Recent Progress in Studying Curcumin and its Nano-preparations for Cancer Therapy
Liu, J., Chen, S., Lv, L., Song, L., Guo, S., & Huang, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289327 · Cited by 68
Polymeric protective agents for nanoparticles in drug delivery and targeting
Mogoşanu, G. D., Grumezescu, A. M., Bejenaru, C., & Bejenaru, L. E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.014 · Cited by 69
Li, W., Chiang, C., Huang, W.-C., Su, C.-W., Chiang, M.-Y., Chen, J.-Y., & Chen, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.020 · Cited by 66
Saneja, A., Khare, V. R., Alam, N., Dubey, R. D., & Gupta, P. N. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.865014 · Cited by 65
Chemotherapeutic drugs induced female reproductive toxicity and treatment strategies
Bhardwaj, J. K., Bikal, P., & Sachdeva, S. N. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23371 · Cited by 63
Gu, Y., Li, J., Li, Y., Song, L., Li, D., Peng, L., Wan, Y., & Hua, S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s118568 · Cited by 62
Polyphenols delivery by polymeric materials: challenges in cancer treatment
Vittorio, O., Curcio, M., Cojoc, M., Goya, G. F., Hampel, S., Iemma, F., Dubrovska, A., & Cirillo, G. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1236846 · Cited by 63
Resveratrol as sensitizer in colorectal cancer plasticity
Brockmueller, A., Sajeev, A., Koklesová, L., Samuel, S. M., Kubatka, P., Büsselberg, D., Kunnumakkara, A. B., & Shakibaei, M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10126-x · Cited by 62
Wang, L., Guan, H., Wang, Z., Xing, Y., Zhang, J., & Cai, K. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01096 · Cited by 58
Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies
Pellacani, C., & Eleftheriou, G. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2020.04.001 · Cited by 60
Dey, S., Sherly, M. C. D., Rekha, M. R., & Sreenivasan, K. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.09.016 · Cited by 58
Grumezescu, A. M., Andronescu, E., Ficai, A., Bleoţu, C., Mihăiescu, D. E., & Chifiriuc, M. C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.063 · Cited by 57
Zhu, X., Zhang, Y., Huang, H., Zhang, H., Hou, L., & Zhang, Z. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328215619583 · Cited by 57
Self-citationWang, S., Yang, W., Cui, J., Li, X., Dou, Y., Su, L., Chang, J. K., Wang, H., Li, X., & Zhang, B. (2015) · Biomaterials Science · doi:10.1039/c5bm00328h · Cited by 55
Prabhuraj, R. S., Bomb, K., Srivastava, R., & Bandyopadhyaya, R. (2020) · Journal of Polymer Research · doi:10.1007/s10965-020-02092-7 · Cited by 55
Ahmed, Z. S. O., Khan, E., Elias, N., Elshebiny, A., & Dou, Q. P. (2025) · Biomolecules · doi:10.3390/biom15050629 · Cited by 54
On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier
Li, H., Li, M., Chen, C., Fan, A., Kong, D., Wang, Z., & Zhao, Y. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.022 · Cited by 54
Nanopharmacology in translational hematology and oncology
Berindan‐Neagoe, I., Braicu, C., Craciun, L., Irimie, A. I., & Takahashi, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s60488 · Cited by 54
Deng, H., Zhao, X., Liu, J., Deng, L., Zhang, J., Liu, J., & Dong, A. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01939g · Cited by 52
Hong, W., Shi, H., Qiao, M., Zhang, Z., Yang, W., Dong, L., Xie, F., Zhao, C., & Li, K. (2017) · Scientific Reports · doi:10.1038/srep42465 · Cited by 52
Codelivery of Hydrophobic and Hydrophilic Drugs by Graphene-Decorated Magnetic Dendrimers
Pourjavadi, A., Asgari, S., Hosseini, S. H., & Akhlaghi, M. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b02710 · Cited by 52
Zhang, W., Li, C., Shen, C., Liu, Y., Zhao, X., Liu, Y., Zou, D., Gao, Z., & Yue, C. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1035466 · Cited by 50
Pourjavadi, A., Asgari, S., & Hosseini, S. H. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101542 · Cited by 50
Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer
Muniraj, N., Siddharth, S., & Sharma, D. (2019) · Cancers · doi:10.3390/cancers11101563 · Cited by 49
Asghar, K., Qasim, M., Dharmapuri, G., & Das, D. (2017) · RSC Advances · doi:10.1039/c7ra03735j · Cited by 47
Sun, L., Deng, X., Yang, X., Li, Z., Wang, Z., Li, L., Wu, Q., Peng, F., Liu, L., & Gong, C. (2014) · RSC Advances · doi:10.1039/c4ra07453j · Cited by 46
Self-citationReddy, K. L., Sharma, P. K., Singh, A. K., Kumar, A., Shankar, K. R., Singh, Y., Garg, N., & Krishnan, V. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.11.007 · Cited by 47
Near-Infrared Light-Triggered Polymeric Nanomicelles for Cancer Therapy and Imaging
Li, L., Pang, X., & Liu, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00648 · Cited by 45
Gupta, P. K., Pappuru, S., Gupta, S., Patra, B., Chakraborty, D., & Verma, R. S. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.03.041 · Cited by 44
Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems
Gao, S., Xu, Y., Asghar, S., Chen, M., Zou, L., Eltayeb, S. E., Huo, M., Ping, Q. N., & Xiao, Y. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1020426 · Cited by 42
Manatunga, D. C., de Silva, R. M., de Silva, K. M. N., Malavige, G. N., Wijeratne, D. T., Williams, G. R., Jayasinghe, C. D., & Udagama, P. V. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.001 · Cited by 42
Metadata
- Authors
- Duan, J., Mansour, H. M., Zhang, Y., Deng, X., Chen, Y., Wang, J., Pan, Y., & Zhao, J.
- Affiliations
- Central South University (CN)
- University of Kentucky (US)
- Emory University (US)
- Corresponding author
- Zhao, Jinfeng
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 426
- Issue
- 1-2
- Pages
- 193-201
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2005475049
- Cited by
- 194
- References
- 38
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 11 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 19 · 2019: 22 · 2018: 18 · 2017: 18 · 2016: 17 · 2015: 19 · 2014: 16 · 2013: 12 · 2012: 5
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lotus Scholars Program (200734)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- multidrug resistance reversal, doxorubicin, curcumin, chitosan, co-encapsulation, MCF-7/ADR cells, breast cancer, anticancer drug delivery, combination chemotherapy
- MeSH terms
- Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Calorimetry, Differential Scanning, Chemistry, Pharmaceutical, Chromatography, Gel, Curcumin, Doxorubicin, Drug Carriers, Drug Combinations, Drug Compounding, Enbucrilate, Female, Humans, Particle Size, Technology, Pharmaceutical, Down-Regulation, Spectroscopy, Fourier Transform Infrared, Drug Resistance, Multiple, ATP Binding Cassette Transporter, Subfamily B, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1, Nanotechnology, Cell Line, Tumor, Chitosan, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review